Intracellular calcium homeostasis in human primary muscle cells from malignant hyperthermia-susceptible and normal individuals. Effect Of overexpression of recombinant wild-type and Arg163Cys mutated ryanodine receptors.
Malignant hyperthermia (MH) is a hypermetabolic disease triggered by volatile anesthetics and succinylcholine in genetically predisposed individuals. Nine point mutations in the skeletal muscle ryanodine receptor (RYR) gene have so far been identified and shown to correlate with the MH-susceptible phenotype, yet direct evidence linking abnormal Ca2+ homeostasis to mutations in the RYR1 cDNA has been obtained for few mutations. In this report, we show for the first time that cultured human skeletal muscle cells derived from MH-susceptible individuals exhibit a half-maximal halothane concentration causing an increase in intracellular Ca2+ concentration which is twofold lower than that of cells derived from MH-negative individuals. We also present evidence demonstrating that overexpression of wild-type RYR1 in cells obtained from MH-susceptible individuals does not restore the MH-negative phenotype, as far as Ca2+ transients elicited by halothane are concerned; on the other hand, overexpression of a mutated RYR1 Arg163Cys Ca2+ channel in muscle cells obtained from MH-negative individuals conveys hypersensitivity to halothane. Finally, our results show that the resting Ca2+ concentration of cultured skeletal muscle cells from MH-negative and MH-susceptible individuals is not significantly different.
Censier
K
K
Department of Anaesthesiology and Research, Kantonsspital/University of Basel, 4031 Basel, Switzerland.
Urwyler
A
A
Zorzato
F
F
Treves
S
S
D001120:Arginine / Q000235:genetics; D015153:Blotting, Western; D002118:Calcium / Q000378:metabolism*; D002478:Cells, Cultured; D003001:Cloning, Molecular; D003553:Cystine / Q000235:genetics; D018076:DNA, Complementary / Q000235:genetics; D019084:Fluorescent Antibody Technique, Indirect; D006221:Halothane / Q000378:metabolism; D006706:Homeostasis; D006801:Humans; D008305:Malignant Hyperthermia / Q000235:genetics* / Q000378:metabolism*; D018482:Muscle, Skeletal / Q000166:cytology / Q000378:metabolism; D016254:Mutagenesis, Insertional; D016133:Polymerase Chain Reaction; D011994:Recombinant Proteins / Q000276:immunology / Q000378:metabolism; D019837:Ryanodine Receptor Calcium Release Channel / Q000235:genetics* / Q000276:immunology / Q000378:metabolism*
D018076:DNA, Complementary; D011994:Recombinant Proteins; D019837:Ryanodine Receptor Calcium Release Channel; D003553:Cystine; D001120:Arginine; D002118:Calcium; D006221:Halothane